Scimago Journal & Country Rank

Adverse Drug Reactions Journal

Country

China

Universities and research institutions in China
Media Ranking in China

Subject Area and Category

Publisher

Chinese Medical Journals Publishing House Co.Ltd

H-Index

4

Publication type

Journals

ISSN

10085734

Coverage

2020-2023

Information

Homepage

How to publish in this journal

cadrj@sina.com

Scope

Adverse Drug Reactions Journal" (Adverse Drug Reactions Journal) is an academic journal published at home and abroad under the supervision of the China Association for Science and Technology and sponsored by the Chinese Medical Association. It was founded in 1999 and is a monthly publication. ISSN 1008-5734. The founder of the magazine, Cheng Jinghua, chief pharmacist, is the main advocate and initiator of China's adverse drug reaction monitoring work. The current editor-in-chief Professor Wang Yuqin is a professor of clinical pharmacology at Capital Medical University, a member of the China Center Group and leader of the Clinical Safety Medication Group of the International Network for Rational Use of Drugs (INRUD) of the National Health and Family Planning Commission, and the Chinese Pharmacological Society Director and honorary chairman of the Professional Committee of Drug-Induced Diseases. "Journal of Adverse Drug Reactions" has a sound editorial committee. Professor Chen Keji, academician of the Academy of Sciences, and Professor Gao Runlin, Zhou Honghao, and Zhong Nanshan, academicians of the Academy of Engineering, serve as consultants. The editorial committee comes from 28 provinces, autonomous regions, municipalities directly under the Central Government (including Taiwan) and the United States, covering clinical medicine ( Cardiovascular, respiratory, digestive, kidney, nervous, mental, endocrine, rheumatic immunity, blood, infection, infection, tumor, allergy, dermatology, etc.), pharmacy (clinical pharmacy, clinical pharmacology, pharmacy, pharmacoeconomics and pharmaceutical management), clinical toxicology, epidemiology and statistics and other professional fields. Join the conversation about this journal
Quartiles

The set of journals have been ranked according to their SJR and divided into four equal groups, four quartiles. Q1 (green) comprises the quarter of the journals with the highest values, Q2 (yellow) the second highest values, Q3 (orange) the third highest values and Q4 (red) the lowest values.

CategoryYearQuartile
Pharmacology2021Q4
Pharmacology2022Q4
Pharmacology2023Q4
Pharmacology (medical)2021Q4
Pharmacology (medical)2022Q4
Pharmacology (medical)2023Q4
SJR

The SJR is a size-independent prestige indicator that ranks journals by their 'average prestige per article'. It is based on the idea that 'all citations are not created equal'. SJR is a measure of scientific influence of journals that accounts for both the number of citations received by a journal and the importance or prestige of the journals where such citations come from It measures the scientific influence of the average article in a journal, it expresses how central to the global scientific discussion an average article of the journal is.

YearSJR
20210.115
20220.125
20230.122
Total Documents

Evolution of the number of published documents. All types of documents are considered, including citable and non citable documents.

YearDocuments
2020193
2021174
2022156
2023141
Citations per document

This indicator counts the number of citations received by documents from a journal and divides them by the total number of documents published in that journal. The chart shows the evolution of the average number of times documents published in a journal in the past two, three and four years have been cited in the current year. The two years line is equivalent to journal impact factor ™ (Thomson Reuters) metric.

Cites per documentYearValue
Cites / Doc. (4 years)20200.000
Cites / Doc. (4 years)20210.124
Cites / Doc. (4 years)20220.134
Cites / Doc. (4 years)20230.103
Cites / Doc. (3 years)20200.000
Cites / Doc. (3 years)20210.124
Cites / Doc. (3 years)20220.134
Cites / Doc. (3 years)20230.103
Cites / Doc. (2 years)20200.000
Cites / Doc. (2 years)20210.124
Cites / Doc. (2 years)20220.134
Cites / Doc. (2 years)20230.100
Total Cites 
Self-Cites

Evolution of the total number of citations and journal's self-citations received by a journal's published documents during the three previous years.
Journal Self-citation is defined as the number of citation from a journal citing article to articles published by the same journal.

CitesYearValue
Self Cites20200
Self Cites202116
Self Cites202229
Self Cites202331
Total Cites20200
Total Cites202124
Total Cites202249
Total Cites202354
External Cites per Doc 
Cites per Doc

Evolution of the number of total citation per document and external citation per document (i.e. journal self-citations removed) received by a journal's published documents during the three previous years. External citations are calculated by subtracting the number of self-citations from the total number of citations received by the journal’s documents.

CitesYearValue
External Cites per document20200
External Cites per document20210.041
External Cites per document20220.054
External Cites per document20230.044
Cites per document20200.000
Cites per document20210.124
Cites per document20220.134
Cites per document20230.103
% International Collaboration

International Collaboration accounts for the articles that have been produced by researchers from several countries. The chart shows the ratio of a journal's documents signed by researchers from more than one country; that is including more than one country address.

YearInternational Collaboration
20201.04
20210.00
20220.64
20230.71
Citable documents 
Non-citable documents

Not every article in a journal is considered primary research and therefore "citable", this chart shows the ratio of a journal's articles including substantial research (research articles, conference papers and reviews) in three year windows vs. those documents other than research articles, reviews and conference papers.

DocumentsYearValue
Non-citable documents20200
Non-citable documents20210
Non-citable documents20225
Non-citable documents20236
Citable documents20200
Citable documents2021193
Citable documents2022362
Citable documents2023517
Cited documents 
Uncited documents

Ratio of a journal's items, grouped in three years windows, that have been cited at least once vs. those not cited during the following year.

DocumentsYearValue
Uncited documents20200
Uncited documents2021173
Uncited documents2022331
Uncited documents2023475
Cited documents20200
Cited documents202120
Cited documents202236
Cited documents202348
% Female Authors

Evolution of the percentage of female authors.

YearFemale Percent
202052.03
202150.15
202240.72
202345.62
Documents cited by public policy (Overton)

Evolution of the number of documents cited by public policy documents according to Overton database.

DocumentsYearValue
Overton20200
Overton20210
Overton20220
Overton20230
Documents related to SDGs (UN)

Evoution of the number of documents related to Sustainable Development Goals defined by United Nations. Available from 2018 onwards.

DocumentsYearValue
SDG202099
SDG202164
SDG202270
SDG202365
Scimago Journal & Country Rank
Show this widget in your own website

Just copy the code below and paste within your html code:
SCImago Graphica
Explore, visually communicate and make sense of data with our new data visualization tool.
Metrics based on Scopus® data as of March 2024
Loading comments…

Leave a comment

* Required

* Required

* Required

* Required

The users of Scimago Journal & Country Rank have the possibility to dialogue through comments linked to a specific journal. The purpose is to have a forum in which general doubts about the processes of publication in the journal, experiences and other issues derived from the publication of papers are resolved. For topics on particular articles, maintain the dialogue through the usual channels with your editor.

Developed by:
Scimago Lab
Powered by:
Powered by scopus

Follow us on @ScimagoJR

Scimago Lab, Copyright 2007-2024. Data Source: Scopus®

Legal Notice

Privacy Policy